scholarly journals Previous COVID-19 Infection and Antibody Levels After Vaccination

2021 ◽  
Vol 9 ◽  
Author(s):  
Hamad Ali ◽  
Barrak Alahmad ◽  
Abdullah A. Al-Shammari ◽  
Abdulmohsen Alterki ◽  
Maha Hammad ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Individual Characteristics ◽  
Linear Regression Models ◽  
Health Authorities ◽  
Previous Infection ◽  
Public Health Authorities ◽  
The Mean ◽  
Vaccine Shortages ◽  
Antibody Levels ◽  
Ig G

Background: The emergence of new COVID-19 variants of concern coupled with a global inequity in vaccine access and distribution has prompted many public health authorities to circumvent the vaccine shortages by altering vaccination protocols and prioritizing persons at high risk. Individuals with previous COVID-19 infection may not have been prioritized due to existing humoral immunity.Objective: We aimed to study the association between previous COVID-19 infection and antibody levels after COVID-19 vaccination.Methods: A serological analysis to measure SARS-CoV-2 immunoglobulin (Ig)G, IgA, and neutralizing antibodies was performed on individuals who received one or two doses of either BNT162b2 or ChAdOx1 vaccines in Kuwait. A Student t-test was performed and followed by generalized linear regression models adjusted for individual characteristics and comorbidities were fitted to compare the average levels of IgG and neutralizing antibodies between vaccinated individuals with and without previous COVID-19 infection.Results: A total of 1,025 individuals were recruited. The mean levels of IgG, IgA, and neutralizing antibodies were higher in vaccinated subjects with previous COVID-19 infections than in those without previous infection. Regression analysis showed a steeper slope of decline for IgG and neutralizing antibodies in vaccinated individuals without previous COVID-19 infection compared to those with previous COVID-19 infection.Conclusion: Previous COVID-19 infection appeared to elicit robust and sustained levels of SARS-CoV-2 antibodies in vaccinated individuals. Given the inconsistent supply of COVID-19 vaccines in many countries due to inequities in global distribution, our results suggest that even greater efforts should be made to vaccinate more people, especially individuals without previous COVID-19 infection.

scholarly journals Previous COVID-19 infection and antibody levels after vaccination

2021 ◽  
Author(s):  
Hamad Ali ◽  
Barrak Alahmad ◽  
Abdullah A. Al-Shammari ◽  
Abdelmohsen Al-Terki ◽  
Maha Hammad ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Regression Models ◽  
Individual Characteristics ◽  
Linear Regression Models ◽  
Serological Analysis ◽  
Health Authorities ◽  
Public Health Authorities ◽  
The Mean ◽  
Vaccine Shortages ◽  
Antibody Levels

AbstractBackgroundThe emergence of new COVID-19 variants of concern coupled with a global inequity in vaccine access and distribution, prompted many public health authorities to circumvent the vaccine shortages by altering vaccination protocols and prioritizing high-risk individuals. Those with previous COVID-19 infection may have not been prioritized due to existing humoral immunity.ObjectiveWe aim to study the association between previous COVID-19 infection and antibody levels after COVID-19 vaccination.MethodsA serological analysis to measure SARS-CoV-2 IgG, IgA and neutralizing antibodies was performed on individuals who received one or two doses of either BNT162b2 or ChAdOx1 vaccines in Kuwait. Generalized linear regression models adjusted for individual characteristics and comorbidities were fitted to study the average levels of IgG and neutralizing antibodies in vaccinated individuals based who had previous COVID-19 infection compared to those who had not.ResultsA total of 1025 individuals were recruited. The mean levels of IgG, IgA and neutralizing antibodies were higher in vaccinated subjects with previous COVID-19 infection when compared with those vaccinated without previous COVID-19 infection. Regression analysis showed a steeper slope of decline for IgG in vaccinated individuals without previous COVID-19 infection in comparison with vaccinated individuals with previous COVID-19 infection.ConclusionPrevious COVID-19 infection appears to elicit robust and sustained levels of SARS-CoV-2 antibodies in vaccinated individuals. Given the inconsistent supply of COVID-19 vaccines in many countries due to the global inequity, our results point towards wider vaccination plans to especially cover individuals without previous COVID-19 infection.

scholarly journals Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination

2021 ◽  
Vol 12 ◽  
Author(s):  
Hamad Ali ◽  
Abdulmohsen Alterki ◽  
Sardar Sindhu ◽  
Barrak Alahmad ◽  
Maha Hammad ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Vaccine Dose ◽  
Individual Characteristics ◽  
Metabolic Conditions ◽  
Antibody Titers ◽  
The Mean ◽  
Antibody Levels ◽  
Robust Response ◽  
Increased Susceptibility

The emergence of effective vaccines for COVID-19 has been welcomed by the world with great optimism. Given their increased susceptibility to COVID-19, the question arises whether individuals with type-2 diabetes mellitus (T2DM) and other metabolic conditions can respond effectively to the mRNA-based vaccine. We aimed to evaluate the levels of anti-SARS-CoV-2 IgG and neutralizing antibodies in people with T2DM and/or other metabolic risk factors (hypertension and obesity) compared to those without. This study included 262 people (81 diabetic and 181 non-diabetic persons) that took two doses of BNT162b2 (Pfizer–BioNTech) mRNA vaccine. Both T2DM and non-diabetic individuals had a robust response to vaccination as demonstrated by their high antibody titers. However, both SARS-CoV-2 IgG and neutralizing antibodies titers were lower in people with T2DM. The mean ( ± 1 standard deviation) levels were 154 ± 49.1 vs. 138 ± 59.4 BAU/ml for IgG and 87.1 ± 11.6 vs. 79.7 ± 19.5% for neutralizing antibodies in individuals without diabetes compared to those with T2DM, respectively. In a multiple linear regression adjusted for individual characteristics, comorbidities, previous COVID-19 infection, and duration since second vaccine dose, diabetics had 13.86 BAU/ml (95% CI: 27.08 to 0.64 BAU/ml, p=0.041) less IgG antibodies and 4.42% (95% CI: 8.53 to 0.32%, p=0.036) fewer neutralizing antibodies than non-diabetics. Hypertension and obesity did not show significant changes in antibody titers. Taken together, both type-2 diabetic and non-diabetic individuals elicited strong immune responses to SARS-CoV-2 BNT162b2 mRNA vaccine; nonetheless, lower levels were seen in people with diabetes. Continuous monitoring of the antibody levels might be a good indicator to guide personalized needs for further booster shots to maintain adaptive immunity. Nonetheless, it is important that people get their COVID-19 vaccination especially people with diabetes.

scholarly journals Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches

PLoS ONE ◽  
2021 ◽  
Vol 16 (11) ◽  
pp. e0259731
Author(s):  
Sara Stinca ◽  
Thomas W. Barnes ◽  
Peter Vogel ◽  
Wilfried Meyers ◽  
Johannes Schulte-Pelkum ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Binding Assay ◽  
Elevated Concentration ◽  
Plasma Pool ◽  
Igg Binding ◽  
Donor Population ◽  
The Mean ◽  
Antibody Levels ◽  
Design And Methods ◽  
Ig G

Background Plasma-derived intravenous immunoglobulin (IVIg) products contain a dynamic spectrum of immunoglobulin (Ig) G reactivities reflective of the donor population from which they are derived. We sought to model the concentration of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG which could be expected in future plasma pool and final-product batches of CSL Behring’s immunoglobulin product Privigen. Study design and methods Data was extracted from accessible databases, including the incidence of coronavirus disease 2019 and SARS-CoV-2 vaccination status, antibody titre in convalescent and vaccinated groups and antibody half-life. Together, these parameters were used to create an integrated mathematical model that could be used to predict anti-SARS-CoV-2 antibody levels in future IVIg preparations. Results We predict that anti-SARS-CoV-2 IgG concentration will peak in batches produced in mid-October 2021, containing levels in the vicinity of 190-fold that of the mean convalescent (unvaccinated) plasma concentration. An elevated concentration (approximately 35-fold convalescent plasma) is anticipated to be retained in batches produced well into 2022. Measurement of several Privigen batches using the Phadia™ EliA™ SARS-CoV-2-Sp1 IgG binding assay confirmed the early phase of this model. Conclusion The work presented in this paper may have important implications for physicians and patients who use Privigen for indicated diseases.

scholarly journals Geography of Microcephaly in the Zika Era: A Study of Newborn Distribution and Socio-environmental Indicators in Recife, Brazil, 2015-2016

2018 ◽  
Vol 133 (4) ◽  
pp. 461-471 ◽  
Author(s):  
Ariani Impieri Souza ◽  
Marília Teixeira de Siqueira ◽  
Ana Laura Carneiro Gomes Ferreira ◽  
Clarice Umbelino de Freitas ◽  
Anselmo César Vasconcelos Bezerra ◽  
...  
Keyword(s):  
Public Hospital ◽  
Incidence Rate Ratio ◽  
Mixed Race ◽  
Environmental Indicators ◽  
The North ◽  
Health Authorities ◽  
Public Health Authorities ◽  
Incidence Risk ◽  
The Mean ◽  
Larvae Density

Objectives: We assessed sociodemographic and health care factors of mothers and newborns during a 2015-2016 outbreak of microcephaly in Recife, Brazil, and we analyzed the spatial distribution and incidence risk of newborns with microcephaly in relation to socio-environmental indicators. Methods: We collected data from August 2015 through May 2016 from Brazil’s Live Birth Information System and Bulletin of Microcephaly Notification, and we geocoded the data by maternal residence. We constructed thematic maps of districts, according to socio-environmental and vector indicators. We identified spatial aggregates of newborns with microcephaly by using the Bernoulli model. We performed logistic regression analyses to compare the incidence risk of microcephaly within socio-environmental indicator groups. Results: We geocoded 17 990 of 19 554 (92.0%) live births in Recife, of which 202 (1.1%) newborns were classified as having microcephaly, based on a head circumference of ≥2 standard deviations below the mean. Larger proportions of newborns with microcephaly (compared with newborns without microcephaly) were born to mothers who delivered in a public hospital, did not attend college, were aged ≤19, or were black or mixed race. A higher risk of microcephaly (incidence rate ratio [IRR] = 3.90; 95% confidence interval [CI], 1.88-8.06) occurred in districts with the lowest (vs highest) Municipal Human Development Index (ie, an index that assesses longevity, education, and income). The risk of microcephaly was significantly higher where rates of larvae density (IRR = 2.31; 95% CI, 1.19-4.50) and larvae detection (IRR = 2.04; 95% CI, 1.05-4.00) were higher and rates of sewage system (IRR = 2.20; 95% CI, 1.16-4.18) and garbage collection (IRR = 1.96; 95% CI, 0.99-3.88) were lower. Newborns with microcephaly lived predominantly in the poorest areas and in a high-risk cluster (relative risk = 1.89, P = .01) in the north. Conclusions: The disproportionate incidence of microcephaly in newborns in poor areas of Recife reinforces the need for government and public health authorities to formulate policies that promote social equity and support for families and their children with microcephaly.

scholarly journals Recent national French food and nutrient intake data

1999 ◽  
Vol 81 (S1) ◽  
pp. S57-S59 ◽  
Author(s):  
Jean-Luc Volatier ◽  
Philippe Verger
Keyword(s):  
Saturated Fat ◽  
Dietary Guidelines ◽  
Fat Intake ◽  
Dietary Survey ◽  
The North ◽  
Health Authorities ◽  
Public Health Authorities ◽  
The Mean ◽  
Food And Nutrient Intake ◽  
Saturated Fat Intake

In France, the first national dietary survey, called ASPCC, was done in 1993–1994. According to this survey, the mean fat intake in France is rather high, both for men (37.7 %) and women (40 %). Saturated fat intake is above 15 % of energy. The intake of fruit and vegetables is particularly low for younger people and manual workers. Fruit intake is also lower for people from the north of the country. These data show the necessity of a targeted nutritional policy in France. Therefore, public health authorities are determining new dietary guidelines. The fact that people with unsatisfactory nutritional status are often not concerned with nutrition proves the importance of simple understandable food-based dietary guidelines.

scholarly journals Epidemiology of meningococcal disease in the Panamanian pediatric population, 1998-2008

2010 ◽  
Vol 5 (05) ◽  
pp. 318-323 ◽  
Author(s):  
Javier Nieto-Guevara ◽  
Kathia Luciani ◽  
Abian Montesdeoca-Melían ◽  
Mercedes Mateos-Durán
Keyword(s):  
Meningococcal Disease ◽  
Pediatric Population ◽  
Circulation Pattern ◽  
Disease Diagnosis ◽  
Invasive Disease ◽  
Epidemiological Surveillance ◽  
Health Authorities ◽  
Public Health Authorities ◽  
The Mean ◽  
One Year

Introduction: Worldwide public health authorities report 500,000 cases of invasive meningococcal disease with 50,000 deaths per year and 10-15% of sequelae in people affected. This study describes the epidemiology, microbiology, and clinical presentation of this disease in the Panamanian pediatric population. Methodology:  The discharge of patients with a meningococcal invasive disease diagnosis was reviewed in the statistical database and archives of the Hospital del Niño. Results: A total of 32 discharges with a meningococcal disease diagnosis were reported during the study period (1998-2008).  Ninety-one percent (n/N = 29/32) were confirmed as meningitis. The mean age of patients was 4.1 ± 4.6 years. The incidence in the period of the study was 0.25/100,000. Infants younger than one year old presented the highest incidence rate and number of cases. Four deaths were reported, three of which occurred in the group of 10-14 years and one in the group of 1-4 years. The overall fatality rate was 12.5%. The serogroup of the causative agent, Neisseria meningitidis, was documented in 30 of the 32 cases, with serogroup B the most frequent (66.7%). Ninety-percent (18/20) of serogroup B were isolated in the first five years of study. Serogroup C was identified in 8 of the 12 cases during the period 2004-2008. Conclusions: The present study showed a change in the epidemiological circulation pattern from serogroup B to serogroup C during the study period. Such epidemiological surveillance data is important in the implementation of preventive measures such as vaccination.

scholarly journals Systemic Antibiotics Influence Periodontal Parameters and Oral Microbiota, But Not Serological Markers

2021 ◽  
Vol 11 ◽  
Author(s):  
Elisa Kopra ◽  
Laura Lahdentausta ◽  
Milla Pietiäinen ◽  
Kåre Buhlin ◽  
Päivi Mäntylä ◽  
...  
Keyword(s):  
Alveolar Bone ◽  
Serum Antibody ◽  
Oral Microbiota ◽  
Microbiota Composition ◽  
Periodontal Pathogens ◽  
Linear Regression Models ◽  
Periodontal Inflammation ◽  
The Mean ◽  
Antibody Levels ◽  
Systemic Antibiotics

The use of systemic antibiotics may influence the oral microbiota composition. Our aim was to investigate in this retrospective study whether the use of prescribed antibiotics associate with periodontal status, oral microbiota, and antibodies against the periodontal pathogens. The Social Insurance Institution of Finland Data provided the data on the use of systemic antibiotics by record linkage to purchased medications and entitled reimbursements up to 1 year before the oral examination and sampling. Six different classes of antibiotics were considered. The Parogene cohort included 505 subjects undergoing coronary angiography with the mean (SD) age of 63.4 (9.2) years and 65% of males. Subgingival plaque samples were analysed using the checkerboard DNA-DNA hybridisation. Serum and saliva antibody levels to periodontal pathogens were analysed with immunoassays and lipopolysaccharide (LPS) activity with the LAL assay. Systemic antibiotics were prescribed for 261 (51.7%) patients during the preceding year. The mean number of prescriptions among them was 2.13 (range 1–12), and 29.4% of the prescriptions were cephalosporins, 25.7% penicillins, 14.3% quinolones, 12.7% macrolides or lincomycin, 12.0% tetracycline, and 5.8% trimethoprim or sulphonamides. In linear regression models adjusted for age, sex, current smoking, and diabetes, number of antibiotic courses associated significantly with low periodontal inflammation burden index (PIBI, p < 0.001), bleeding on probing (BOP, p = 0.006), and alveolar bone loss (ABL, p = 0.042). Cephalosporins associated with all the parameters. The phyla mainly affected by the antibiotics were Bacteroidetes and Spirochaetes. Their levels were inversely associated with the number of prescriptions (p = 0.010 and p < 0.001) and directly associated with the time since the last prescription (p = 0.019 and p < 0.001). Significant inverse associations were observed between the number of prescriptions and saliva concentrations of Prevotella intermedia, Tannerella forsythia, and Treponema denticola and subgingival bacterial amounts of Porphyromonas gingivalis, P. intermedia, T. forsythia, and T. denticola. Saliva or serum antibody levels did not present an association with the use of antibiotics. Both serum (p = 0.031) and saliva (p = 0.032) LPS activity was lower in patients having any antibiotic course less than 1 month before sampling. Systemic antibiotics have effects on periodontal inflammation and oral microbiota composition, whereas the effects on host immune responses against the periodontal biomarker species seem unchanged.

scholarly journals The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera

2021 ◽  
Author(s):  
Sonia Jangra ◽  
Chengjin Ye ◽  
Raveen Rathnasinghe ◽  
Daniel Stadlbauer ◽  
Florian Krammer ◽  
...  
Keyword(s):  
Negative Control ◽  
Spike Protein ◽  
Health Authorities ◽  
Previous Infection ◽  
Public Health Authorities ◽  
Human Sera ◽  
The Usa ◽  
One Year ◽  
Study Participants

AbstractOne year in the coronavirus disease 2019 (COVID-19) pandemic, the first vaccines are being rolled out under emergency use authorizations. It is of great concern that newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can escape antibody-mediated protection induced by previous infection or vaccination through mutations in the spike protein. The glutamate (E) to Lysine (K) substitution at position 484 (E484K) in the receptor binding domain (RBD) of the spike protein is present in the rapidly spreading variants of concern belonging to the B.1.351 and P.1 lineages. We performed in vitro microneutralization assays with both the USA-WA1/2020 virus and a recombinant (r)SARS-CoV-2 virus that is identical to USA-WA1/2020 except for the E484K mutation introduced in the spike RBD. We selected 34 sera from study participants based on their SARS-CoV-2 spike ELISA antibody titer (negative [N=4] versus weak [N=8], moderate [N=11] or strong positive [N=11]). In addition, we included sera from five individuals who received two doses of the Pfizer SARS-CoV-2 vaccine BNT162b2. Serum neutralization efficiency was lower against the E484K rSARS-CoV-2 (vaccination samples: 3.4 fold; convalescent low IgG: 2.4 fold, moderate IgG: 4.2 fold and high IgG: 2.6 fold) compared to USA-WA1/2020. For some of the convalescent donor sera with low or moderate IgG against the SARS-CoV-2 spike, the drop in neutralization efficiency resulted in neutralization ID50 values similar to negative control samples, with low or even absence of neutralization of the E484K rSARS-CoV-2. However, human sera with high neutralization titers against the USA-WA1/2020 strain were still able to neutralize the E484K rSARS-CoV-2. Therefore, it is important to aim for the highest titers possible induced by vaccination to enhance protection against newly emerging SARS-CoV-2 variants. Two vaccine doses may be needed for induction of high antibody titers against SARS-CoV-2. Postponing the second vaccination is suggested by some public health authorities in order to provide more individuals with a primer vaccination. Our data suggests that this may leave vaccinees less protected against newly emerging variants.

scholarly journals Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination

2021 ◽  
Author(s):  
Hamad Ali ◽  
Abdulmohsen Al-Terki ◽  
Sardar Sindhu ◽  
Barrak Alahmad ◽  
Maha Hammad ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Vaccine Dose ◽  
Individual Characteristics ◽  
Metabolic Conditions ◽  
Antibody Titers ◽  
Antibody Levels ◽  
Type 2 Diabetic ◽  
Robust Response ◽  
Increased Susceptibility

The emergence of effective vaccines for COVID-19 has been welcomed by the world with great optimism. Given their increased susceptibility to COVID-19, the question arises whether individuals with type-2 diabetes mellitus (T2DM) and other metabolic conditions can respond effectively to the mRNA-based vaccine. We aimed to evaluate the levels of anti-SARS-CoV-2 IgG and neutralizing antibodies in people with T2DM and/or other metabolic risk factors (hypertension and obesity) compared to those without. This study included 262 people that took two doses of BNT162b2 (Pfizer-BioNTech) mRNA vaccine. Both T2DM and non-diabetic individuals had a robust response to vaccination as demonstrated by their high antibody titers. However, both SARS-CoV-2 IgG and neutralizing antibodies titers were lower in people with T2DM. Their levels were 154±49.1 vs. 138±59.4BAU/mL for IgG and 87.1±11.6 vs. 79.7±19.5% for neutralizing antibodies in individuals without diabetes compared to those with T2DM, respectively. In a multiple linear regression adjusted for individual characteristics, comorbidities, previous COVID-19 infection and duration since second vaccine dose, diabetics had 13.86 BAU/ml (95%CI: -27.08 to -0.64BAU/ml, p=0.041) less IgG antibodies and 4.42% (95%CI: -8.53 to -0.32%, p=0.036) less neutralizing antibodies than non-diabetics. Hypertension and obesity did not show significant changes in antibody titers. Taken together, both type-2 diabetic and non-diabetic individuals elicited strong immune responses to SARS-CoV-2 BNT162b2 mRNA vaccine; nonetheless, lower levels were seen in people with diabetes. Continuous monitoring of the antibody levels might be a good indicator to guide personalized needs for further booster shots to maintain adaptive immunity.

scholarly journals Spreadable Virus of the 21stCentuary: COVID-19

2020 ◽  
Vol 21 (1&2) ◽  
pp. 13-18
Author(s):  
Priya Chaudhary ◽  
Pracheta Janmeda
Keyword(s):  
Treatment Process ◽  
Preventive Measures ◽  
Ground Glass Opacity ◽  
Nasal Discharge ◽  
The Public ◽  
The Third ◽  
Health Authorities ◽  
Public Health Authorities ◽  
The Mean ◽  
Novel Coronavirus

The latest outbreak of a respiratory disease, known as coronavirus disease 19 (COVID-19), is the third virus spillover from animals to humans in the last two decades. The disease is caused by coronavirus and has converted into an epidemic in recent days. It spread via direct contact or droplets of nasal-discharge from one human-to-another within the mean-incubation period of 6.5 days. Dyspnea, cough and fever are the most common symptoms in the patients of COVID-19, though along with diarrhea in 3% cases. Bilateral pulmonary with ground-glass opacity and consolidation has been observed in 98% cases of the disease by the help of computed tomography.  The treatment process of COVID-19 with chloroquine and remdesivir drug is under the clinical trial worldwide and responding well to cure the disease. Under the prevalent circumstances, the main goal is to control the widespread infection of SARS-CoV-2 across the world and to aware the public regarding the possible preventive measures and treatments. However, the public health authorities should keep a close eye on the circumstances strictly, as the more we know about this novel coronavirus and its outbreak, the better we can respond or control the conditions worldwide.

Sign in / Sign up

Export Citation Format

Share Document